Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kieran F Docherty

Showing results (11-20 of 174) with videos related to

Pageof 18
Sort By:
The British Journal of Cardiology|June 24, 2022
Foundational drugs for HFrEF: the growing evidence for a rapid sequencing strategyKieran F Docherty, John J V McMurray
Cardiovascular Research|September 10, 2019
PIONEER-HF: a new frontier in the role of neprilysin inhibition in the management of heart failure with reduced ejection fractionKieran F Docherty, John J V McMurray
Journal of the American College of Cardiology|August 17, 2019
Phosphodiesterase-9 Inhibition in Heart Failure: A Further Opportunity to Augment the Effects of Natriuretic Peptides?John J V McMurray, Kieran F Docherty
Clinical Cardiology|July 5, 2022
Insights into foundational therapies for heart failure with reduced ejection fractionJohn J V McMurray, Kieran F Docherty
JACC. Heart Failure|June 5, 2024
The Link Between Heart Failure and Neurodegeneration: Insights From Circulating BiomarkersJan Traub, Kieran F Docherty, Anna Frey
JACC. Heart Failure|November 8, 2025
Vericiguat: VICTORy or Defeat?Kieran F Docherty, John J V McMurray
International Journal of Cardiology|June 13, 2018
Angiotensin receptor-neprilysin inhibitors: A new paradigm in heart failure with reduced ejection fractionKieran F Docherty, John J V McMurray
European Journal of Heart Failure|December 7, 2020
SOLOIST-WHF and updated meta-analysis: sodium-glucose co-transporter 2 inhibitors should be initiated in patients hospitalized with worsening heart failureKieran F Docherty, John J V McMurray
European Journal of Heart Failure|September 3, 2024
Heart failure medical therapy in the last years of life: Prognosis and practicalitiesDaniel J Doherty, Amr Abdin, Kieran F Docherty
Heart (British Cardiac Society)|January 8, 2024
Review of the National Institute for Health and Care Excellence guidelines on chronic heart failureDaniel J Doherty, Kieran F Docherty, Roy S Gardner
Pageof 18

Showing results (11-20 of 174) with videos related to

Sort By:
Pageof 18
The British Journal of Cardiology|June 24, 2022
Foundational drugs for HFrEF: the growing evidence for a rapid sequencing strategyKieran F Docherty, John J V McMurray
Cardiovascular Research|September 10, 2019
PIONEER-HF: a new frontier in the role of neprilysin inhibition in the management of heart failure with reduced ejection fractionKieran F Docherty, John J V McMurray
Journal of the American College of Cardiology|August 17, 2019
Phosphodiesterase-9 Inhibition in Heart Failure: A Further Opportunity to Augment the Effects of Natriuretic Peptides?John J V McMurray, Kieran F Docherty
Clinical Cardiology|July 5, 2022
Insights into foundational therapies for heart failure with reduced ejection fractionJohn J V McMurray, Kieran F Docherty
JACC. Heart Failure|June 5, 2024
The Link Between Heart Failure and Neurodegeneration: Insights From Circulating BiomarkersJan Traub, Kieran F Docherty, Anna Frey
JACC. Heart Failure|November 8, 2025
Vericiguat: VICTORy or Defeat?Kieran F Docherty, John J V McMurray
International Journal of Cardiology|June 13, 2018
Angiotensin receptor-neprilysin inhibitors: A new paradigm in heart failure with reduced ejection fractionKieran F Docherty, John J V McMurray
European Journal of Heart Failure|December 7, 2020
SOLOIST-WHF and updated meta-analysis: sodium-glucose co-transporter 2 inhibitors should be initiated in patients hospitalized with worsening heart failureKieran F Docherty, John J V McMurray
European Journal of Heart Failure|September 3, 2024
Heart failure medical therapy in the last years of life: Prognosis and practicalitiesDaniel J Doherty, Amr Abdin, Kieran F Docherty
Heart (British Cardiac Society)|January 8, 2024
Review of the National Institute for Health and Care Excellence guidelines on chronic heart failureDaniel J Doherty, Kieran F Docherty, Roy S Gardner
Pageof 18